This document is a daily equity report from Epic Research India, an investment advisory firm, dated January 8, 2019. It includes the closing levels of major Indian stock indices, sectoral indices, and analysis and recommendations for specific stocks. The key points are: - The Nifty closed up 0.41% and the Sensex closed up 0.43%. Most sectoral indices closed up marginally except for Pharma and Metal. - In analyst speaks, Nifty is seen forming an open broadening pattern and advice is given to buy on declines around 10720-10740 with a stop loss of 10600 and target of 10830-10950. - For Bank Nifty, advice is to

1. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
DAILY EQUITY REPORT
Our Presence
Epic Research India
411 Milinda Manor (Suites 409- 417)
2 RNT Marg. Opp Central Mall
Indore (M.P.)
Hotline: +91 731 664 2300
Or give us a missed call at
026 5309 0639
HNI & NRI Sales Contact Australia
Mintara Road, Tarneit, Victoria. Post Code 3029
Phone.: +61 422 063855
HNI & NRI Sales Contact USA
2117 Arbor Vista Dr. Charlotte (NC)
Cell: +1 704 249 2315
Toll Free Number
1-800-200-9454
All queries should be directed to
Info@epicresearch.co

2. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
DAILY MARKET WRAPUP
INDIAN INDICES
INDEX CMP Change % Chg
NIFTY 10771 44.45 0.41
SENSEX 35850 155.06 0.43
-0.16
Index Current % Change Open High Low Prev. Close
AUTO 8,818.85 0.11 8,891.90 8,901.60 8,809.90 8,809.35
FIN SERVICE 11,591.65 0.17 11,635.65 11,663.55 11,575.90 11,572.45
FMCG 30,289.05 0.33 30,440.90 30,491.20 30,241.90 30,190.20
IT 14,304.80 1.12 14,238.05 14,313.55 14,204.65 14,146.15
MEDIA 2,526.45 0.29 2,539.10 2,544.30 2,509.60 2,519.15
METAL 2,998.35 -0.11 3,040.65 3,055.30 2,991.45 3,001.70
PHARMA 8,737.00 -0.58 8,840.60 8,847.15 8,711.50 8,788.05
PSU BANK 3,113.55 -0.37 3,159.15 3,164.15 3,097.80 3,125.10
REALTY 238.7 1.19 237.75 242.1 237.6 235.9
ENERGY 14,144.20 0.72 14,130.40 14,243.15 14,095.65 14,043.05
INFRA 3,145.90 0.49 3,147.50 3,171.70 3,135.90 3,130.65
MNC 13,623.25 0.29 13,685.15 13,713.75 13,606.55 13,584.20
PSE 3,347.70 0.49 3,348.05 3,358.55 3,338.40 3,331.45
SERV SECTOR 14,943.85 0.5 14,959.40 14,994.40 14,913.35 14,868.85
GROWSECT 15 6,311.05 0.07 6,361.85 6,363.20 6,301.50 6,306.40

3. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
EPIC RESEARCH– ANALYST SPEAKS
Nifty followed global market and started with gap up but today PSU and Metal share made pressure in market due to that whole day Nifty traded
in sideways and in last one hour it loosed almost fifty per cent gains in intraday. On daily chart it created bearish candle since Nifty forming
Open Broadening pattern so we it will be buy in decline around 10720-10740 with stop loss o 10600 for the target of 10830 10950.
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
10870 10820 10785 10735 10700
NIFTY

4. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
EPIC RESEARCH– ANALYST SPEAKS
Bank Nifty future traded at last four month highs but PSU banks made pressure on index due to that it could not sustain at higher level and
finished with breaish Marubozu candle on daily chart. On RSI it has negative divergence and it is forming channel line pattern since the last
session was side ways so it can be buy with stop loss of 27050 which is previous week low for the target of 27500.
BANKNIFTY
RESISTANCE 2 RESISTANCE 1 PIVOT SUPPORT 1 SUPPORT 2
27551 27427 27353 27229 27155

5. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
EPIC RESEARCH– ANALYST SPEAKS
Stock is consolidating for a couple of weeks and performed well today. We have seen a good recovery in the last couple of hours in the trading
session. it also closed above the 200 EMA on the daily chart. We recommend buying above 922 for the target of 930 with the stop loss of 914.
EPIC RESEARCH– ANALYST SPEAKS
BEML FUTURE

6. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
EPIC RESEARCH– ANALYST SPEAKS
After a week of the correction phase stock has shown good strength on the daily chart and closed in green. It also closed above the 200 EMA on the
daily chart. We recommend buying above 1182 for the target of 1197 with the stop loss of 1169.
AJANTPHARM FUTURE

7. YOUR MINTVISORY Call us at +91-731-6642300
08 JAN 2019
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any
responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up
on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility.
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually
tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and
encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on
the information given in this report, which is in violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks
recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of
the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any
financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer
to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then
Serious Legal Actions can be taken.
DISCLAIMER